ALRN
Price
$2.11
Change
+$0.18 (+9.33%)
Updated
Jan 10 closing price
Capitalization
45.72M
KZIA
Price
$1.42
Change
-$0.05 (-3.42%)
Updated
Jan 17 closing price
Capitalization
7.13M
Ad is loading...

ALRN vs KZIA

Header iconALRN vs KZIA Comparison
Open Charts ALRN vs KZIABanner chart's image
Aileron Therapeutics
Price$2.11
Change+$0.18 (+9.33%)
Volume$63.39K
Capitalization45.72M
Kazia Therapeutics
Price$1.42
Change-$0.05 (-3.42%)
Volume$36.79K
Capitalization7.13M
ALRN vs KZIA Comparison Chart
Loading...
ALRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KZIA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALRN vs. KZIA commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALRN is a Hold and KZIA is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (ALRN: $2.11 vs. KZIA: $1.41)
Brand notoriety: ALRN and KZIA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALRN: 58% vs. KZIA: 39%
Market capitalization -- ALRN: $45.72M vs. KZIA: $7.13M
ALRN [@Biotechnology] is valued at $45.72M. KZIA’s [@Biotechnology] market capitalization is $7.13M. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALRN’s FA Score shows that 1 FA rating(s) are green whileKZIA’s FA Score has 0 green FA rating(s).

  • ALRN’s FA Score: 1 green, 4 red.
  • KZIA’s FA Score: 0 green, 5 red.
According to our system of comparison, ALRN is a better buy in the long-term than KZIA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALRN’s TA Score shows that 4 TA indicator(s) are bullish while KZIA’s TA Score has 3 bullish TA indicator(s).

  • ALRN’s TA Score: 4 bullish, 3 bearish.
  • KZIA’s TA Score: 3 bullish, 2 bearish.
According to our system of comparison, both ALRN and KZIA are a good buy in the short-term.

Price Growth

ALRN (@Biotechnology) experienced а 0.00% price change this week, while KZIA (@Biotechnology) price change was -10.44% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.66%, and the average quarterly price growth was -1.92%.

Reported Earning Dates

ALRN is expected to report earnings on May 08, 2023.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALRN($45.7M) has a higher market cap than KZIA($7.13M). ALRN YTD gains are higher at: -8.261 vs. KZIA (-20.056). KZIA has higher annual earnings (EBITDA): -17.52M vs. ALRN (-29.5M). ALRN (0) and KZIA (0) have equivalent revenues.
ALRNKZIAALRN / KZIA
Capitalization45.7M7.13M641%
EBITDA-29.5M-17.52M168%
Gain YTD-8.261-20.05641%
P/E RatioN/AN/A-
Revenue00-
Total Cash17.7MN/A-
Total Debt0N/A-
FUNDAMENTALS RATINGS
ALRN vs KZIA: Fundamental Ratings
ALRN
KZIA
OUTLOOK RATING
1..100
253
VALUATION
overvalued / fair valued / undervalued
1..100
18
Undervalued
53
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9899
PRICE GROWTH RATING
1..100
6498
P/E GROWTH RATING
1..100
80100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ALRN's Valuation (18) in the Pharmaceuticals Major industry is somewhat better than the same rating for KZIA (53) in the Biotechnology industry. This means that ALRN’s stock grew somewhat faster than KZIA’s over the last 12 months.

ALRN's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as KZIA (100) in the Biotechnology industry. This means that ALRN’s stock grew similarly to KZIA’s over the last 12 months.

ALRN's SMR Rating (98) in the Pharmaceuticals Major industry is in the same range as KZIA (99) in the Biotechnology industry. This means that ALRN’s stock grew similarly to KZIA’s over the last 12 months.

ALRN's Price Growth Rating (64) in the Pharmaceuticals Major industry is somewhat better than the same rating for KZIA (98) in the Biotechnology industry. This means that ALRN’s stock grew somewhat faster than KZIA’s over the last 12 months.

ALRN's P/E Growth Rating (80) in the Pharmaceuticals Major industry is in the same range as KZIA (100) in the Biotechnology industry. This means that ALRN’s stock grew similarly to KZIA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALRNKZIA
RSI
ODDS (%)
Bullish Trend 11 days ago
85%
Bullish Trend 11 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 11 days ago
84%
N/A
Momentum
ODDS (%)
Bullish Trend 11 days ago
83%
N/A
MACD
ODDS (%)
Bullish Trend 11 days ago
82%
N/A
TrendWeek
ODDS (%)
Bearish Trend 11 days ago
90%
Bearish Trend 11 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 11 days ago
90%
Bearish Trend 11 days ago
87%
Advances
ODDS (%)
Bullish Trend 24 days ago
78%
Bullish Trend 20 days ago
81%
Declines
ODDS (%)
Bearish Trend 11 days ago
89%
Bearish Trend 11 days ago
87%
BollingerBands
ODDS (%)
N/A
Bullish Trend 11 days ago
86%
Aroon
ODDS (%)
Bearish Trend 11 days ago
88%
Bearish Trend 11 days ago
83%
View a ticker or compare two or three
Ad is loading...
ALRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KZIA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ATNM1.400.18
+14.75%
Actinium Pharmaceuticals
PSTL13.05-0.01
-0.08%
Postal Realty Trust
NUVL75.84-0.15
-0.20%
Nuvalent
TRV239.52-2.85
-1.18%
Travelers Companies (The)
CMTG3.86-0.07
-1.78%
Claros Mortgage Trust

ALRN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALRN has been closely correlated with RNTX. These tickers have moved in lockstep 99% of the time. This A.I.-generated data suggests there is a high statistical probability that if ALRN jumps, then RNTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALRN
1D Price
Change %
ALRN100%
N/A
RNTX - ALRN
99%
Closely correlated
+1.52%
SRZN - ALRN
44%
Loosely correlated
+1.94%
KZIA - ALRN
35%
Loosely correlated
-3.08%
INAB - ALRN
30%
Poorly correlated
-0.13%
ERNA - ALRN
29%
Poorly correlated
-5.97%
More

KZIA and

Correlation & Price change

A.I.dvisor indicates that over the last year, KZIA has been loosely correlated with HOOK. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is some statistical probability that if KZIA jumps, then HOOK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KZIA
1D Price
Change %
KZIA100%
-3.08%
HOOK - KZIA
66%
Loosely correlated
+0.52%
FRES - KZIA
56%
Loosely correlated
N/A
ALRN - KZIA
36%
Loosely correlated
N/A
CLNN - KZIA
33%
Poorly correlated
-2.04%
RVMD - KZIA
29%
Poorly correlated
+0.98%
More